HighTower Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.86M | Buy |
228,386
+251
| +0.1% | +$10.8K | 0.01% | 800 |
|
|
2025
Q1 | $7.89M | Sell |
228,135
-197
| -0.1% | -$6.81K | 0.01% | 862 |
|
|
2024
Q4 | $6.27M | Buy |
228,332
+5,001
| +2% | +$137K | 0.01% | 953 |
|
|
2024
Q3 | $5.69M | Buy |
223,331
+22,077
| +11% | +$562K | 0.01% | 981 |
|
|
2024
Q2 | $5.1M | Buy |
201,254
+1,992
| +1% | +$50.5K | 0.01% | 996 |
|
|
2024
Q1 | $6.16M | Sell |
199,262
-1,019
| -0.5% | -$31.5K | 0.01% | 879 |
|
|
2023
Q4 | $8.09M | Buy |
200,281
+1,045
| +0.5% | +$42.2K | 0.01% | 764 |
|
|
2023
Q3 | $5.25M | Sell |
199,236
-24,377
| -11% | -$643K | 0.01% | 910 |
|
|
2023
Q2 | $3.84M | Buy |
223,613
+15,000
| +7% | +$258K | 0.01% | 1015 |
|
|
2023
Q1 | $3.46M | Buy |
208,613
+228
| +0.1% | +$3.78K | 0.01% | 1019 |
|
|
2022
Q4 | $1.59M | Hold |
208,385
| – | – | ﹤0.01% | 1404 |
|
|
2022
Q3 | $2.07M | Hold |
208,385
| – | – | 0.01% | 1209 |
|
|
2022
Q2 | $1.89M | Buy |
208,385
+115
| +0.1% | +$1.04K | ﹤0.01% | 1286 |
|
|
2022
Q1 | $2.12M | Sell |
208,270
-10,652
| -5% | -$108K | ﹤0.01% | 1345 |
|
|
2021
Q4 | $3.65M | Buy |
218,922
+7,284
| +3% | +$122K | 0.01% | 1055 |
|
|
2021
Q3 | $9.92M | Sell |
211,638
-10,130
| -5% | -$475K | 0.03% | 533 |
|
|
2021
Q2 | $13.5M | Buy |
221,768
+3
| +0% | +$183 | 0.04% | 413 |
|
|
2021
Q1 | $13.7M | Buy |
221,765
+1,357
| +0.6% | +$83.6K | 0.04% | 390 |
|
|
2020
Q4 | $15.7M | Buy |
220,408
+100
| +0% | +$7.11K | 0.07% | 278 |
|
|
2020
Q3 | $8.27M | Hold |
220,308
| – | – | 0.04% | 388 |
|
|
2020
Q2 | $7.18M | Hold |
220,308
| – | – | 0.04% | 410 |
|
|
2020
Q1 | $6.39M | Buy |
+220,308
| New | +$6.39M | 0.04% | 386 |
|